MedTrace Logo

Functional Outcome After Treatment for Oropharyngeal Squamous Cell Carcinoma

NCT03418909 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2023-03-30

No results posted yet for this study

Summary

To investigate the treatment related effects of transoral robotic surgery (TORS) or oncological treatment of oropharyngeal squamous cell carcinoma with a 1-year follow up.

Conditions

Interventions

PROCEDURE

Primary Trans Oral Robotic Surgery (TORS)

In the absence of severe mobidity patients with early stage disease (T1-2, N1, M0) were offered TORS, as an alternative to the standard of care (radiotherapy).

RADIATION

Radio(chemo)therapy

As the standard of care radiotherapy was offered to all of the patients. Patients that qualified for both TORS and radiotherapy were free to choose between the two.

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    lead OTHER

Principal Investigators

  • Christian von Buchwald, MD, dr. med. · Rigshospitalet, Denmark

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-01
Primary Completion
2021-12-31
Completion
2024-06-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03418909 on ClinicalTrials.gov